Immunostimulatory PyNTTTTGT oligodeoxynucleotides: Structural properties and refinement of the active motif

Oligonucleotides

Volumn 16, Issue 3, 2006, Pages 275-285

  Rodriguez, Juan M ^a   Elías, Fernanda ^a   Fló, Juan ^a   López, Ricardo A ^a   Zorzopulos, Jorge ^a   Montaner, Alejandro D ^a  

^a Immunotech SA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CYTIDINE; DEOXYRIBONUCLEOTIDE; DINUCLEOTIDE; DOUBLE STRANDED DNA; HYDROXYL GROUP; IMMUNOSTIMULATING AGENT; METHYL GROUP; OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; ORGANOPHOSPHATE; PHOSPHORIC ACID DERIVATIVE; PHOSPHOROTHIOIC ACID; RNA; SYNTHETIC DNA; THYMIDINE;

ARTICLE; B LYMPHOCYTE ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; DNA STRUCTURE; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOSTIMULATION; NUCLEOTIDE SEQUENCE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; VERTEBRATE;

ADJUVANTS, IMMUNOLOGIC; B-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; OLIGODEOXYRIBONUCLEOTIDES;

VERTEBRATA;

EID: 33751101366     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2006.16.275     Document Type: Article

References (34)

1. BEIGNON, A.S., MCKENNA, K., SKOBERNE, M., MANCHES, O., DASILVA, I., KAVANAGH, D.G., LARSSON, M., GORELICK, R.J., LIFSON, J.D., and BHARDWAJ, N. (2005). Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 5, 3265-3275.
2. CARPENTIER, A.F., CHEN, L., MALTONI, F., and DELATTRE, J.Y. (1999). Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice. Cancer Res. 59, 5429-5432.
3. CHU, R.S., TARGONI, O.S., KRIEG, A.M., LEHMAN, P.V., and HARDING, C.V. (1997). CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186, 1623-1631.
4. 12 and the influence of phosphorothioate substitution. Nucleic Acids Res. 25, 4098-4106.
5. COOPER, C.L., DAVIS, H.L., MORRIS, M.L., EFLER, S.M., AL ADHAMI, M., KRIEG, A.M., CAMERON, D.W., and HEATHCOTE, J. (2004). CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B® HBV vaccine in healthy adults: A double-blind phase I/II study. J. Clin. Immunol. 24, 693-701.
6. DAVIS, H.L., WEERATNA, R., WALDSCHMIDT, T.J., TYGRETT, L., SCHORR, J., and KRIEG, A.M. (1998). CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160, 870-876.
7. DIEBOLD, S.S., KAISHO, T., HEMMI, H., AKIRA, S., and REIS E SOUSA, C. (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531.
8. ELIAS, F., FLO, J., LOPEZ, R.A., ZORZOPULOS, J., MONTANER, A., and RODRÍGUEZ, J.M. (2003). Strong CpG independent immunostimulation in humans and other primates by synthetic oligodeoxynucleotides with PyNTTTTGT motifs. J. Immunol. 171, 3697-3704.
9. HALPERIN, S.A., DOBSON, S., MCNEILL, S., LANGLEY, J.M., SMITH, B., MACCALL-SANI, R., LEVITT, D., VAN NEST, G., GENNEVOIS, D., and EIDEN, J.J. (2006). Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults. Vaccine 24, 20-26.
10. HARTMANN, G., and KRIEG, A.M. (2000). Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164, 944-952.
11. HARTMANN, G., WEERATNA, R., BALLAS, Z.K., PAYETTE, P., SUPARTO, I., RASMUSSEN, W.L., WADSCHMIDT, M., SAJUTHI, D., PURCELLS, R.H., DAVIS, H.L., and KRIEG, A.M. (2000). Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164, 1617-1624.
12. HARTMANN, G., BATTIANY, J., POECK, H., WAGNER, M., KERKMANN, M., LUBENOW, N., ROTHENFUSSER, S., and ENDRES, S. (2003). Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-α induction in plasmacytoid dendritic cells. Eur. J. Immunol. 33, 1633-1641.
13. JAROSZEWSKI, J.W., CLAUSEN, V., COHEN, J.S., and DAHL, O. (1996). NMR investigations of duplex stability of phosphorothioate and phosphorothioate DNA analogues modified in both strands. Nucleic Acids Res. 24, 829-834.
14. + dendritic cells to produce type IIFN. J. Immunol. 166, 2291-2295.
15. KLINE, J.N., BUSINGA, T.R., WALDSCHMIDT, T.J., WEINSTOCK, J.V., and KRIEG, A.M. (1998). Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. immunol. 15, 2555-2559.
16. KRIEG, A.M. (2002). GpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709-760.
17. KRIEG, A.M., YI, A.K., MATSON, S., WALDSCHMIT, T.J., BISHOP, G.A., TEASDALE, R., KORETZKY, G.A., and KLINMAN, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
18. KRIEG, A.M., WU, T., WEERATNA, R., EFLER, S.M., LOVE-HOMAN, L., YANG, L., YI, A.K., SHORT, D., and DAVIS, H.L. (1998). Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. U.S.A. 12, 631-636.
19. KRUG, A., ROTHENFUSSER, S., HORMUNG, V., JAHRSDORFER, B., BLACKWELL, S., BALLAS, Z.K., ENDRES, S., KRIEG, A.M., and HARTMANN, G. (2001a). Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells. Eur. J. Immunol. 31, 2154-2163.
20. KRUG, A., TOWAROWSKI, A., BRITSCH, S., ROTHENFUSSE, S., HORNUNG, V., BALS, R., GIESE, T., ENGELMANN, H., ENDRES, S., KRIEG, A.M., and HARTMANN, G. (2001b). Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31, 3026-3037.
21. LENERT, P., STUNZ, L.L., YI, A.K., KRIEG, A.M., and ASHMAN, R.F. (2001). CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-κB activation. Antisense Nucleic Acid Drug Dev. 11, 247-256.
22. LIANG, H., NISHIOKA, Y., REICH, C.F., PISETSKY, D.S., and LIPSKY, P.E. (1996). Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98, 1119-1129.
23. LIPFORD, G.B., BAUER, M., BLANK, C., REITER, R., WAGNER, H., and HEEG, K. (1997). CpG-containing synthetic oligodeoxynucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants. Eur. J. Immunol. 27, 2340-2344.
24. MAGONE, M.T., CHAN, C.C., BECK, L., WHITCUP, S.M., and RAZ, E. (2000). Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis. Eur. J. Immunol. 30, 1841-1850.
25. MOLDOVENU, G.J., LOVE-HOMAN, L., HUANG, W.Q., and KRIEG, A.M. (1998). CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16, 1216-1224.
26. SPARWASSER, T., KOCH, E.S., VABULAS, R.M., HEEG, K., LIPFORD, G.B., ELLWART, J.W., and WAGNER, H. (1998). Bacterial DNA and immunostimulatory CpG oligodeoxynucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28, 2045-2054.
27. STEIN, C.A., SUBASINGHE, C., SHINOZUKA, K., and COHEN, J.S. (1988). Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 16, 3209-3221.
28. VERTHELYI, D., ISHII, K.J., GURSEL, M., TAKESHITA, F., and KLINMAN, D.M. (2001). Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J. Immunol. 166, 2372-2377.
29. VOLLMER, J., JANOSCH, A., LAUCHT, M., BALLAS, Z.K., SCHETTER, C., and KRIEG, A.M. (2002). Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes. Antisense Nucleic Acid Drug Dev. 12, 165-175.
30. WEERATNA, R., MCCLUSKIE, M.J., YU, X., and DAVIS, H.L. (2000). CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine 18, 1755-1762.
31. WOOLDRIDGE, J.E., BALLAS, Z., KRIEG, A.M., and WEINER, G.J. (1997). Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma. Blood 89, 2994-2998.
32. XU, Y. (2006). DNA damage: A trigger of innate immunity but a requirement for adaptive immune homeostasis. Nat. Rev. Immunol. 6, 261-270.
33. ZELENAY, S., ELIAS, F., and FLO, J. (2003). Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides. Eur. J. Immunol. 33, 1382-1392.
34. ZHAO, Q., MATSON, S., HERRERA, C.J., FISHER, E., YU, H., and KRIEG, A.M. (1993). Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res Dev. 3, 53-66.